Skip to main content
TeamingIndex
Unclaimed profileSeeded from SAM.gov and USAspending public records

INTACT GENOMICS INC

UEIZR9GABSXHMY8CAGE6ZS47NAICS325414
  • SAM active
  • No verified credentials yet
  • CMMCNot on file
  • SPRSNone
  • FCLVisible to paid members
  • Small Business
  • Small Disadvantaged Business

Registration and small-business types: SAM.gov, synced Nov 9, 2026. Compliance: self-attested by the company unless marked verified. The SPRS chip shows a range, never the exact score. How verification works

36-mo obligations
$0
Awards on record
0
Contract vehicles
0
Verified credentials
0

Compliance posture: unverified (SAM.gov baseline only)

INTACT GENOMICS INC has not claimed this profile. What you see comes from public SAM.gov and USAspending records; no one from the company has confirmed CMMC, SPRS or clearance details yet. Learn more about CMMC 2.0

Claim this profile

About INTACT GENOMICS INC

INTACT GENOMICS INC is a SAM.gov-registered entity based in SAINT LOUIS, MO 63146-3318. UEI ZR9GABSXHMY8; CAGE 6ZS47; primary NAICS 325414. Compliance posture not provided. Active SAM registration.
Headquarters
SAINT LOUIS, MO 63146-3318

Identifiers

UEI and CAGE come from SAM.gov. Other identifiers are listed by the company.

  • UEIZR9GABSXHMY8
  • CAGE6ZS47

Capabilities & differentiators

No capability narrative yet

The company has not published a capability narrative. Its SAM.gov registration, NAICS codes and award history are below.

Compliance posture

Every credential shows who vouches for it: verified by TeamingIndex, or self-attested by the contractor.

No compliance posture published yet

Compliance facts appear once the company claims this profile and publishes them.

Facility clearance

Facility clearance: visible to paid members

Clearance levels are shown only to paying members; TeamingIndex does not advertise clearances (NISPOM 32 CFR 117.9). Learn more about facility clearances · Compare plans

No federal prime awards on record

USAspending shows no prime awards for this UEI in the last 36 months. Subcontract work does not appear here.

No contract vehicles on file

This company has not listed GWAC, IDIQ, GSA Schedule or OTA consortium holdings.
Who INTACT GENOMICS INC has actually worked with, from sub-awards that prime contractors report to the government. Use it to see which primes already trust this company.

No sub-award reports yet

Prime contractors report first-tier subcontracts of $30,000 or more. None name this company yet, which is common for companies that mostly win prime contracts or work below the reporting threshold.

Source: USAspending.gov sub-award reports (FSRS) (opens in a new tab) · sync date not recorded · Prime contractors report first-tier subcontracts of $30,000 or more. Amounts are reported sub-award values.

Small Business Innovation Research and Technology Transfer awards: early-stage federal R&D money this company has won.

SBIR/STTR awardee — Phase III-eligible for work derived from its SBIR/STTR projects

Agencies may award follow-on Phase III work without a new competition when it builds on this company’s earlier SBIR/STTR projects. Other work is competed as usual.

Awards on record
11 awards
Total awarded
$12,430,364
By phase
  • SBIR Phase I: 6
  • SBIR Phase II: 5
By agency
  • Department of Health and Human Services: 11
Active projects
0 projects
Projects whose contract end date is today or later.
Phase II ending within 12 months
0 projects
Phase II projects ending within 12 months. Agencies may award Phase III work without a new competition only when it derives from, extends or completes these projects.
By year
  • 2023: 1
  • 2022: 1
  • 2020: 1
  • 2019: 1
  • 2018: 2
  • 2016: 3
  • 2015: 1
  • 2014: 1

Awards (most recent first)

  • A Platform to Identify Antifungal Compounds with Novel Action Mechanisms

    SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2023 · $300,156

    Jul 19, 2023 – Jun 30, 2024

    Solicitation PA22-176 (2022) · Topic R43

  • Rapid dissection of the biosynthesis of antiMRSA antibiotics produced in co-culture by extremophilic fungi through the development of Fungal Artificial Chromosomes

    SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2022 · $2,942,798

    Jul 1, 2022 – Jun 30, 2025

    Solicitation PA21-259 (2021) · Topic NIAID

  • Rapid discovery of thousands of intact biosynthetic gene pathways for bioactive natural product compounds from un-sequenced filamentous fungi using a novel FAC-NGS tool

    SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2020 · $3,000,000

    Feb 1, 2020 – Jan 31, 2023

    Solicitation PA18-574 (2018) · Topic NIAID

  • Rapid discovery of thousands of intact biosynthetic gene pathways for bioactive natural product compounds from un-sequenced filamentous fungi using a novel FAC-NGS tool

    SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2019 · $300,000

    Jan 15, 2019 – Dec 31, 2019

    Solicitation PA18-574 (2018) · Topic NIAID

  • Rapid dissection of the biosynthesis of antiMRSA antibiotics produced in co-culture by extremophilic fungi through the development of Fungal Artificial Chromosomes

    SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2018 · $229,472

    Jul 5, 2018 – Jun 30, 2019

    Solicitation PA17-302 (2017) · Topic NIAID

  • A robust heterologous expression system of intact fungal secondary metabolite gene clusters for natural product discovery in Aspergillus nidulans

    SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2018 · $1,496,230

    Jun 1, 2018 – May 31, 2020

    Solicitation PA17-302 (2017) · Topic NCCIH

  • Activate Silent and Cryptic Intact Fungal SM Gene Clusters through FACs for Novel Antibiotics Discovery

    SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2016 · $1,773,324

    Jul 15, 2016 – Dec 31, 2018

    Solicitation PA15-269 (2015) · Topic NIAID

  • A robust heterologous expression system of intact fungal secondary metabolite gene clusters for natural product discovery in Aspergillus nidulans

    SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2016 · $224,868

    Apr 1, 2016 – Mar 31, 2017

    Solicitation AT16-003 (2015) · Topic R

  • Single kb kb molecule sequencing to rapid and cost effectively assemble high quality arthropod genomes de novo

    SBIR Phase I · Department of Health and Human Services (Centers for Disease Control and Prevention) · 2016 · $149,727

    Solicitation year 2016 · Topic ODCDC

  • Activate Silent and Cryptic Intact Fungal SM Gene Clusters through FACs for Novel Antibiotics Discovery

    SBIR Phase I · Department of Health and Human Services (National Institutes of Health) · 2015 · $211,454

    Jan 15, 2015 – Jun 30, 2016

    Solicitation PA14-071 (2015) · Topic NIAID

  • Expanding small molecule functional metagenomics through shuttle BAC expression i

    SBIR Phase II · Department of Health and Human Services (National Institutes of Health) · 2014 · $1,802,335

    May 15, 2014 – Jun 30, 2016

    Solicitation PA13-234 (2014) · Topic NIAID

Source: SBIR.gov award data file (opens in a new tab) · as of Nov 12, 2026 · file published Nov 1, 2026

Cloud services this company lists on the FedRAMP Marketplace, the government's record of cloud authorizations.

No FedRAMP Marketplace listing

No FedRAMP Marketplace listing is linked to this company. Cloud providers appear here automatically once FedRAMP lists their offering.

Source: FedRAMP Marketplace (opens in a new tab) · sync date not recorded

Checks a prime runs before teaming: SAM.gov exclusions (debarment and suspension) and the government's Consolidated Screening List for export and sanctions lists.

SAM.gov exclusions

Not yet checked against SAM.gov exclusions.

Search exclusions on SAM.gov (opens in a new tab)

Agencies generally may not award to excluded parties, and primes may not subcontract with them above the threshold in FAR 52.209-6 (except COTS items) without a compelling reason reported to the contracting officer (FAR 9.405, 9.405-2). Some exclusion types apply only to specific programs: read the record on SAM.gov.

Source: SAM.gov Exclusions (opens in a new tab) · sync date not recorded

Consolidated Screening List

No confirmed match on the Consolidated Screening List (screened Nov 13, 2026).

The list combines Commerce, State and Treasury export-control and sanctions lists. A “no match” result is a name-and-address screen, not an export-compliance determination.

Hourly ceiling rates this company was awarded on GSA contracts, compared with the market for similar labor categories. Ceiling rates are the most an agency can be charged, not prices paid.

No GSA CALC+ rates on record

Companies with a GSA Multiple Award Schedule contract appear here after CALC+ publishes their awarded labor rates.

NAICS, PSC & socio-economic status

Industry codes and small-business programs reported in SAM.gov.

NAICS codes

  • 325414Biological Product (except Diagnostic) ManufacturingPrimarySmall business under this code’s size standard
  • 325199Title not in the curated listSmall business under this code’s size standard

SAM.gov reports this entity as small under 2 of 2 NAICS codes. Size is determined per code (SBA size standards).

Product & service codes (PSC)

  • 6550IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS
  • 6640LABORATORY EQUIPMENT AND SUPPLIES
  • 6810CHEMICALS
  • AA11AGRICULTURE R&D SERVICES; AGRICULTURAL RESEARCH AND SERVICES; BASIC RESEARCH
  • AA12AGRICULTURE R&D SERVICES; AGRICULTURAL RESEARCH AND SERVICES; APPLIED RESEARCH
  • AA13AGRICULTURE R&D SERVICES; AGRICULTURAL RESEARCH AND SERVICES; EXPERIMENTAL DEVELOPMENT

PSC names from the Acquisition.gov PSC Manual (opens in a new tab) (April 2025 edition), checked Nov 12, 2026.

This company has not published teaming preferences.

SAM.gov teaming eligibility: Eligible to be proposed as a team member: active SAM.gov registration and no exclusion.

Business development contact

No BD contact published

Contact details appear once the company claims this profile.
Immediate parent and highest-level owner as reported in SAM.gov.

No parent entity reported in SAM.gov.

SBA counts affiliates when it determines whether a business is small (13 CFR 121.103), so a parent’s size can matter for set-aside work.

Data sources & provenance

Who stands behind each fact on this page, and how to correct it.
  • SAM.gov

    Registration, CAGE, NAICS, socio-economic status, corporate hierarchy and exclusions. Last synced Nov 9, 2026.

  • USAspending.gov

    Prime award history and obligations (FPDS), synced nightly.

  • The contractor

    Nothing yet: this profile has not been claimed by the company.

  • TeamingIndex verification

    Credentials marked Verified were checked by a TeamingIndex reviewer; everything else is self-attested.

Corrections

Corrections to SAM.gov data must be made in SAM.gov; TeamingIndex picks them up on the next nightly sync. Go to SAM.gov (opens in a new tab)

Machine-readable: capability.md schema.org JSON-LD embedded in this page.

Zero CUI: TeamingIndex stores verification metadata only, never System Security Plans, POA&Ms or DD Form 254s.

Teaming

Ready to team with INTACT GENOMICS INC?

Send an introduction and propose a mutual NDA. Their team is notified right away, and you can share the capability statement with your capture team.